INSIDER
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources

Public disclosures only. Scores flag unusual patterns and are not evidence of wrongdoing. Not investment advice.

RH CHAIN…
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
01Overview02Follow the Money03Daily Brief04Live05Congress06Corporate Insiders07Government Money08Political Influence09Institutions10Washington Network11Follow the Power12Disclosure Clock13AI Investigator14Watchlist
ConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
OverviewFollow the MoneyDaily BriefLiveCongressCorporate InsidersGovernment MoneyPolitical InfluenceInstitutionsWashington NetworkFollow the PowerDisclosure ClockAI InvestigatorWatchlistConvergenceINSIDER AlphaSignal ledgerHistorical ReplayRobinhood ChainProofTradingTokenProAccountMethodologyMatch reviewLaunch readiness
Data sources
SEC FORM 44h ago
HOUSE PTR4h ago
SEC 13F4h ago
ROBINHOOD CHAIN4h ago
Corporate insider
VV

Vakiener Victoria

DirectorCIK 0001826263

EDGAR filingsOpen in network
Disclosed transactions4
Buys / sells0 / 3
Max Insider Score17
Connections1with evidence

Disclosed transactions

ScoreActorSecuritySideValueExecutedDisclosedLagSourceEvidence
12
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$186K
2,799 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

Verified connections

  • Insider ofevidence
    ARROWHEAD PHARMACEUTICALS, INC.Director · Dec 18, 2025
15
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL
$359K
5,281 sh
Dec 19, 2025
Dec 23, 2025
traded Dec 19, 2025
+4d
SEC FORM 4

Evidence

12
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Open-market sale · 10b5-1 plan
SELL$134K
1,960 sh
Dec 19, 2025Dec 23, 2025
traded Dec 19, 2025
+4dSEC FORM 4

Evidence

17
VV
Vakiener VictoriaDirector
ARWRARROWHEAD PHARMACEUTICALS, INC.
Grant or award
A—
7,819 sh
Dec 16, 2025Dec 18, 2025
traded Dec 16, 2025
+2dSEC FORM 4

Evidence